Cambridge Healthtech Institute’s 12th Annual
Advances in Immunotherapy
Modulating the Immune System against Cancer and Autoimmune Disorders
May 11-12, 2027
Cambridge Healthtech Institute’s 12th Annual Advances in Immunotherapy conference explores the latest breakthroughs shaping the future of immunotherapy across oncology, autoimmune disease, and other immune-mediated disorders. Key topics include overcoming resistance, targeting the TME, identifying new targets, and mechanisms for anticancer immunity. The program will also examine the engineering of safer, more effective cell therapies and immune cell engagers for treating solid tumors and autoimmune disease. Presentations will span both adoptive and innate immune approaches, encompassing immune-based therapies, protein therapeutics, and other emerging immunotherapy platforms.
Coverage will include, but is not limited to:
- Overcoming Resistance and Limitations in Immunotherapy
- Overcoming resistance and the tumor microenvironment
- Immunocytokines and next-generation immunotherapy advances
- Next-generation checkpoints, oncolytics, and latest advances
- Impact of microbiome on immunotherapy responses
- Immune Cell Engagers and Innate Immunity
- Myeloid and macrophage cell engager updates
- NK engagers and TriKEs clinical updates
- Gamma delta and MAIT engager platforms
- TLR and STING agonists via antibodies
- Immunotherapies for Autoimmune and I&I
- CD19 BCMA mRNA CAR T experience
- Treg and CAR Treg therapy landscape
- Lymphodepletion-free approaches, durability, and redosing
- Cell and immunotherapy approaches for autoimmune
- Dark Antigens
- Immunopeptidomics-driven dark-antigen discovery
- Peptide HLA platforms for intracellular oncoproteins
- Shared off-the-shelf dark antigens
- Derisking programs through cross-reactivity screening
- Immunotherapies against Solid Tumors
- Strategies to overcome solid tumor barrier
- TCR T and next-wave targets
- Peptide HLA targeting via cell therapy
- Cell therapies against solid tumors
The deadline for priority consideration is October 23, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation:
- To submit a podium presentation, please click here.
- To become a sponsor, click here.
- To present a poster, click here.
- To sign up to attend, click here.